11:23 AM
 | 
Mar 12, 2018
 |  BC Extra  |  Company News

Biogen scoops up neuropsychiatry candidate from Pfizer

Biogen Inc. (NASDAQ:BIIB) will acquire neuropsychiatry candidate PF-04958242 from Pfizer Inc. (NYSE:PFE) for $75 million up front. The pharma is eligible for $515 million in milestones, plus tiered...

Read the full 119 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >